While safe for many people, they can have side effects like nausea, vomiting, and diarrhoea
Conversely, if Novo Nordisk successfully extends certain patent protections, the timeline could be pushed back further
Semaglutide (the active ingredient in Ozempic, Wegovy, compounded injections, and oral versions) is a glucagon-like peptide-1 (GLP-1) receptor agonist that is very effective for long-term weight management
Clinical trials have demonstrated that patients can lose between 10% to 20% of their body weight, depending on the medication and adherence to treatment
Each production batch receives comprehensive HPLC analysis before release, with results documented in Certificates of Analysis that accompany shipments to customers worldwide